00:34:07 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Elos Medtech är verksamma inom medicinteknik. Bolaget arbetar med forskning och utveckling av produkter och medicintekniska komponenter för dentala- och ortopediska implantat. Verksamheten bedrivs via egna anläggningar runtom Norden, Nordamerika och Asien. Kunderna utgörs huvudsakligen av internationellt verksamma företagskunder. Huvudkontoret ligger i Göteborg.

Kalender

2024-02-22 Bokslutskommuniké 2023
2023-10-19 Kvartalsrapport 2023-Q3
2023-07-14 Kvartalsrapport 2023-Q2
2023-05-03 Årsstämma 2023
2023-04-26 Kvartalsrapport 2023-Q1
2023-02-23 Bokslutskommuniké 2022
2022-10-21 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-04 Ordinarie utdelning ELOS B 0.00 SEK
2022-05-03 Årsstämma 2022
2022-04-26 Kvartalsrapport 2022-Q1
2022-02-24 Bokslutskommuniké 2021
2021-12-22 Extra Bolagsstämma 2021
2021-10-20 Kvartalsrapport 2021-Q3
2021-07-16 Kvartalsrapport 2021-Q2
2021-05-04 Ordinarie utdelning ELOS B 1.50 SEK
2021-05-03 Årsstämma 2021
2021-04-28 Kvartalsrapport 2021-Q1
2021-02-24 Bokslutskommuniké 2020
2020-10-20 Kvartalsrapport 2020-Q3
2020-07-16 Kvartalsrapport 2020-Q2
2020-05-05 Kvartalsrapport 2020-Q1
2020-04-22 Ordinarie utdelning ELOS B 0.00 SEK
2020-04-21 Årsstämma 2020
2020-02-18 Bokslutskommuniké 2019
2019-10-24 Kvartalsrapport 2019-Q3
2019-07-18 Kvartalsrapport 2019-Q2
2019-04-24 Ordinarie utdelning ELOS B 1.00 SEK
2019-04-23 Kvartalsrapport 2019-Q1
2019-04-23 Årsstämma 2019
2019-02-18 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-07-19 Kvartalsrapport 2018-Q2
2018-04-25 Ordinarie utdelning ELOS B 0.00 SEK
2018-04-24 Kvartalsrapport 2018-Q1
2018-04-24 Årsstämma 2018
2018-02-19 Bokslutskommuniké 2017
2017-10-24 Kvartalsrapport 2017-Q3
2017-08-25 Kvartalsrapport 2017-Q2
2017-04-27 Ordinarie utdelning ELOS B 1.30 SEK
2017-04-26 Årsstämma 2017
2017-04-26 Kvartalsrapport 2017-Q1
2017-02-24 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-24 Kvartalsrapport 2016-Q2
2016-04-27 Ordinarie utdelning ELOS B 1.00 SEK
2016-04-26 Kvartalsrapport 2016-Q1
2016-04-26 Årsstämma 2016
2016-02-25 Bokslutskommuniké 2015
2015-10-23 Kvartalsrapport 2015-Q3
2015-08-21 Kvartalsrapport 2015-Q2
2015-04-28 Ordinarie utdelning ELOS B 2.00 SEK
2015-04-28 Bonusutdelning ELOS B 1
2015-04-27 Kvartalsrapport 2015-Q1
2015-04-27 Årsstämma 2015
2015-02-19 Bokslutskommuniké 2014
2014-10-24 Kvartalsrapport 2014-Q3
2014-08-22 Kvartalsrapport 2014-Q2
2014-04-30 Ordinarie utdelning ELOS B 2.00 SEK
2014-04-29 Kvartalsrapport 2014-Q1
2014-04-29 Årsstämma 2014
2014-02-21 Bokslutskommuniké 2013
2013-10-23 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-04-26 Ordinarie utdelning ELOS B 1.00 SEK
2013-04-25 Årsstämma 2013
2013-04-25 Kvartalsrapport 2013-Q1
2013-02-22 Bokslutskommuniké 2012
2012-10-26 Kvartalsrapport 2012-Q3
2012-08-22 Kvartalsrapport 2012-Q2
2012-04-24 Ordinarie utdelning ELOS B 1.50 SEK
2012-04-23 Årsstämma 2012
2012-04-23 Kvartalsrapport 2012-Q1
2012-02-24 Bokslutskommuniké 2011
2011-10-26 Kvartalsrapport 2011-Q3
2011-08-18 Kvartalsrapport 2011-Q2
2011-05-04 Ordinarie utdelning ELOS B 1.50 SEK
2011-05-03 Årsstämma 2011
2011-05-03 Kvartalsrapport 2011-Q1
2011-02-25 Bokslutskommuniké 2010
2010-10-27 Kvartalsrapport 2010-Q3
2010-08-19 Kvartalsrapport 2010-Q2
2010-04-29 Ordinarie utdelning ELOS B 0.00 SEK
2010-04-28 Kvartalsrapport 2010-Q1
2010-02-25 Bokslutskommuniké 2009
2009-10-23 Kvartalsrapport 2009-Q3
2009-08-20 Kvartalsrapport 2009-Q2
2009-04-30 Ordinarie utdelning ELOS B 1.50 SEK
2009-04-29 Årsstämma 1
2009-04-29 Kvartalsrapport 2009-Q1
2008-04-29 Ordinarie utdelning ELOS B 1.50 SEK
2007-04-26 Ordinarie utdelning ELOS B 0.50 SEK
2006-04-28 Ordinarie utdelning ELOS B 1.25 SEK
2005-05-20 Split ELOS B 1:2
2005-05-04 Ordinarie utdelning ELOS B 2.50 SEK
2004-04-30 Ordinarie utdelning ELOS B 0.00 SEK
2003-05-07 Ordinarie utdelning ELOS B 0.00 SEK
2002-04-26 Ordinarie utdelning ELOS B 0.00 SEK
2001-04-27 Ordinarie utdelning ELOS B 2.25 SEK
1995-06-15 Split ELOS B 1:2
2022-05-03 14:30:00

Elos Medtech held its Annual General Meeting ("AGM") on Tuesday 3 May 2022. The AGM was carried out, pursuant to temporary statutory rules, through advance voting only, without any physical attendance. The AGM resolved inter alia the following:

Adoption of income statements and balance sheets for 2021 and discharge of liability

The AGM adopted the income statements and balance sheets for the company and the group included in the annual report for the financial year 2021. The AGM resolved to discharge the members of the Board of Directors and the CEO from liability in respect of their management of the company's business during the financial year 2021.

Allocation of profits

The AGM resolved that no dividend for the financial year 2021 shall be paid to the shareholders and that the company's unrestricted equity of SEK 287,832,937 shall be carried forward.

Election of Board members and auditor, and determination of remuneration to the Board of Directors and auditor

The AGM resolved, in accordance with the nomination committee's proposal, that the number of Board Members shall be five (5) without deputies and the number of auditors shall be one (1) without deputies.

The AGM resolved, in accordance with the nomination committee's proposal, to re-elect Lovisa Lander, Birker B. Bahnsen, Alexander Cicetti and Stefano Alfonsi as members of the Board of Directors. Magnus René was elected new member of the Board of Directors. All elections for the period until the end of the next AGM. Furthermore, Stefano Alfonsi was elected as new Chairman of the Board of Directors. The registered accounting firm KPMG AB was re-elected as the company's auditor, with the authorized public accountant Johan Kratz as the auditor in charge.

The AGM resolved, in accordance with the nomination committee's proposal, that remuneration shall be paid with SEK 500,000 to the Chairman of the Board of Directors and with SEK 250,000 to each of the other Board members, and that remuneration for additional efforts of a consultancy nature may be paid to Board members within a framework of SEK 100,000, to be distributed in accordance with the Board of Directors' decision.

The Board members which are dependent in relation to the majority holder TA Associates shall not receive remuneration.

Furthermore, the AGM resolved, in accordance with the nomination committee's proposal, that the fee to the auditor shall be paid in accordance with approved invoices.

Principles for the appointment of the Nomination Committee

The AGM resolved, in accordance with the nomination committee's proposal, to approve the principles for the appointment of the nomination committee, as set out in the notice to the AGM. The principles are the same as last year with the amendment that the principles will apply until further notice. 

Approval of the Board of Director's remuneration report

The AGM resolved to approve the Board of Directors' remuneration report for the fiscal year 2021.

Minutes from the AGM together with complete decisions will be provided at the company's webpage, www.elosmedtech.com.

For more information, please contact:

Jodie Gilmore, interim CEO, President & Business Unit Director Orthopedics, +1 901 323 6699, jodie.gilmore@elosmedtech.com
Ewa Linsäter, CFO, +46 76 633 32 33, ewa.linsater@elosmedtech.com

For more information about the Elos Medtech Group, please see www.elosmedtech.com